Pharmadrug Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-28
Interim MD&A - English.pdf
Results 2026-05-28
Interim financial statements/report – English.pdf
News 2026-05-13
PharmaDrug Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus
News release - English.pdf
Results 2026-04-30
Annual MD&A - English.pdf
Results 2026-04-30
Audited annual financial statements – English.pdf
News 2026-01-16
Early warning report.pdf
Transactions 2026-01-06 M&A
PharmaDrug Inc. Closes First Tranche of Acquisition of Canurta Limited Partnership, Issues Shares and Enters into Forgivable Promissory Note
Material change report - English.pdf
News 2026-01-05
Report of exempt distribution (45-106F1).pdf
Transactions 2026-01-05 M&A
PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring
News release - English.pdf
News 2025-12-21
Report of exempt distribution (45-106F1).pdf
Results 2025-11-24 Financials
Interim MD&A - English.pdf
Results 2025-11-24 Financials
Interim financial statements/report – English.pdf
News 2025-10-31
News release - English.pdf
News 2025-10-30
News release - English.pdf
Results 2025-08-22 Financials
Interim MD&A - English.pdf
Results 2025-08-22 Financials
Interim financial statements/report – English.pdf
News 2025-07-30
News release - English.pdf
News 2025-07-30
News release - English.pdf
News 2025-06-16
News release - English.pdf
News 2025-06-06
News release - English.pdf